Biotech China 2014
Making the Right Investments in Biomedical Informatics for Drug Development and Healthcare
Gaylord National Hotel & Convention Center
201 Waterfront Street
National Harbor, Maryland 20745
http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=23256&eventType=Meeting
 How Health Care Data can be Used to Expand the Evidence Base and Promote
   Cost-eff ective Health Outcomes This is the age of opportunity for
   health care! There is now so much health care data available that when
   it is aggregated, analyzed, mined and visualized it can provide the
   information needed to enable evidence-based, cost-eff ective, better
   health care. Biomedical Informatics is the scientifi c discipline that
   optimizes the access to and use of biomedical and health care
   information for the benefit of public health. This conference is about
   Biomedical Informatics. It sets out to identify the critical questions
   of public health policy, drug discovery and development, health care
   delivery, and begins to address how biomedical informatics is
   fundamental to advances in these areas. CRITICAL QUESTIONS INCLUDE :
   1. How do we encourage participation in the clinical research
   enterprise? Is integrative biomedical informatics the key to
   maximizing the value of what is learned from clinical trials? 2. How
   do drugs in the same therapeutic class compare in terms of safety and
   eff ectiveness? What do we know about diff erences in comparative
   safety and eff ectiveness by patient subpopulations? 3. How much do we
   know about drug safety and eff ectiveness at the time of drug
   approval? How can analytics maximize continued learning post approval?
   4. How quickly and accurately can we detect and understand new safety
   signals? What are the practical challenges of obtaining, integrating,
   and analyzing the necessary data? 5. What Risk Evaluation and
   Mitigation Strategies ( REMS ) would ensure that drug benefi ts
   outweigh risks while minimizing added health care costs and
   maintaining patient access? 6. Do key health care stakeholders have
   access to the right information, of the right quality, at the right
   time, to make the best-informed decisions?


   201 Waterfront Street, National Harbor, MD, 20745, United States

   Loading (May not complete on browsers without Javascript support)...

   Try again

Schedule of Presentations:

Wednesday, October 13, 2010
08:00:00 Registration
09:15:00 SESSION 1: Plenary Keynote – Integrative Informatics in R&D
10:30:00 THEME A - Application of Biomedical Informatics to Health Care and Pharma: Semantic Web in Health Care and Pharma Susie M Stephens
10:35:00 Using Semantic Technologies to Develop Platforms for Public-Private Secondary Use of Health Care Data Joris Van Dam
11:00:00 Barriers and Solutions to Clinical Practice and the Development of Personalized Medicine: InterLinking Data from Bedside to Bench Chimezie Ogbuji, Chris Domarew
11:30:00 THEME B - Policy of Biomedical Informatics in Health Care and Pharma: Comparative Effectiveness Research John Cuddeback
11:35:00 History, Current State, and Future of CER Anne E Trontell
11:45:00 Data Resources and Methods for Observational Studies
12:00:00 Policy Issues: Optimizing Health Outcomes and Cost-Eff ectiveness
12:15:00 Lunch
13:30:00 THEME A - Application of Biomedical Informatics to Health Care and Pharma: Clinical Research and Health Care Data Quality and Integrity Catherine Celingant
13:35:00 Functional Requirements of Clinical Metadata Repositories David A. Evans
13:45:00 Getting the Right Data to Provide Biomarkers for Clinical Research David Aronow
14:00:00 THEME B - Policy of Biomedical Informatics in Health Care and Pharma: Informatics and The New Generation of Clinical Research and Care John Speakman
15:00:00 Break
15:30:00 THEME A - Application of Biomedical Informatics to Health Care and Pharma: Predictive Analytics in Health Care and Pharma John C. M. Wise
15:35:00 Data Repositories: The Foundation for Analytics
15:45:00 Life Science Opportunities Enabled by Analytics & ClinicalTrials.gov Eric Neumann
16:00:00 Optimizing Clinical Trials with Modeling & Simulation Bernd Doetzkies
16:15:00 THEME B - Policy of Biomedical Informatics in Health Care and Pharma: Meaningful Use of Electronic Health Care Records Mitra Rocca
16:20:00 Meaningful Use – An Industry Perspective Michael N. Cantor
16:40:00 Meaningful Use and HIT Architectures for Health Care Innovation and Transformation Kenneth D Mandl
17:00:00 End of Day 1
Thursday, October 14, 2010
09:15:00 Keynote - Health Informatics
10:30:00 THEME A - Application of Biomedical Informatics to Health Care and Pharma: Predictive Analytics in Health Care and Pharma Paul A. Bleicher
10:35:00 Outcomes Research Validity Using an EMR Database Richard Tannen
10:45:00 Look Before You Leap: Visual Exploration of Health Care Data for Hypothesis Framing Sigfried Gold, Marc Cohen
11:00:00 THEME B - Policy of Biomedical Informatics in Health Care and Pharma: FDAAA: Sentinel Initiative Richard Platt
11:05:00 The progress the Sentinel Initiative has made towards meeting this ambitious mandate Mark Weiner, Judy Racoosin, Sean Hennessy
12:00:00 Lunch
13:00:00 SESSION 7 - Regulatory / Pharma / Health Care Interactive Panel Discussion Theresa M. Mullin, Ronald D. Fitzmartin
13:05:00 Transformational capability of biomedicalinformatics to change the way we do clinical R&D and deliver health care. Paul A. Bleicher, John Speakman, Richard Platt, Janet Woodcock
15:00:00 Summary and Close of Meeting Ronald D. Fitzmartin, Theresa M. Mullin
4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.